Nocturia Global Market Report 2025

Description

Nocturia is a medical condition characterized by the need to wake up at night one or more times to urinate. It is classified as a lower urinary tract symptom (LUTS) and can stem from various underlying causes, such as excessive fluid intake before bedtime, overactive bladder, urinary tract infections, diabetes, or prostate enlargement in men. Nocturia can significantly affect sleep quality and overall health, leading to fatigue and reduced daytime productivity.

The primary drugs used for nocturia treatment include anticholinergic drugs, desmopressin, antibiotics, antispasmodics, and other medications. Anticholinergic drugs work by blocking acetylcholine to reduce involuntary bladder contractions, helping to manage overactive bladder and nocturia. These medications are indicated for conditions such as mixed nocturia, low nocturnal bladder capacity, nocturnal polyuria, and global polyuria. Nocturia can be caused by factors such as urological infections, bladder tumors, diuretic medications, alcohol or caffeine consumption, liver infections, diabetes, and pregnancy. These treatments are utilized by various end users, including hospitals, home care settings, and clinics.

The nocturia market research report is one of a series of new reports from The Business Research Company that provides nocturia market statistics, including the nocturia industry global market size, regional shares, competitors with the nocturia market share, detailed nocturia market segments, market trends, and opportunities, and any further data you may need to thrive in the nocturia industry. This nocturia market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The nocturia market size has grown strongly in recent years. It will grow from $2.87 billion in 2024 to $3.11 billion in 2025 at a compound annual growth rate (CAGR) of 8.4%. The growth during the historic period can be attributed to the increasing prevalence of cardiovascular diseases, a rising incidence of insomnia, an aging population, greater awareness of nocturia and related conditions, and a rise in comorbidities.

The nocturia market size is expected to see strong growth in the next few years. It will grow to $4.23 billion in 2029 at a compound annual growth rate (CAGR) of 8.0%. The growth during the forecast period can be attributed to the increasing prevalence of bladder obstruction disorders and urinary tract inflammation, a rising incidence of nocturia due to various risk factors, high fluid intake contributing to nocturia, growing awareness of its connection to sleep disorders and kidney health, and the expanding aging population. Key trends in the forecast period include advancements in diagnostics, the development of new drugs, increased research and investment in nocturia treatments, progress in both surgical and non-surgical treatment options, and the adoption of personalized medicine.

The increasing prevalence of cardiovascular diseases is expected to drive the expansion of the nocturia market. Cardiovascular diseases (CVDs) encompass a range of disorders affecting the heart and blood vessels, including heart disease, stroke, and hypertension. Several factors contribute to the growing incidence of cardiovascular diseases, such as aging populations, sedentary lifestyles, unhealthy diets, smoking, excessive alcohol consumption, obesity, high blood pressure, high cholesterol, diabetes, and genetic predisposition. Nocturia is a common symptom among patients with cardiovascular diseases, leading to increased demand for diagnostic and treatment solutions. As cardiovascular conditions continue to rise globally due to aging and unhealthy lifestyles, the need for effective nocturia management will expand. For example, in May 2024, the Centers for Disease Control and Prevention, a US-based government agency, reported that heart disease was responsible for 702,880 deaths in the United States in 2022, accounting for 20% of all fatalities. Each year, approximately 805,000 individuals suffer a heart attack, with 605,000 being first-time cases and 200,000 occurring in those with a prior history. Consequently, the rising prevalence of cardiovascular diseases is fueling the growth of the nocturia market.

Leading companies in the nocturia market are focusing on developing innovative treatments, such as orally disintegrating tablets, to improve patient convenience and compliance. Orally disintegrating tablets (ODTs) are solid dosage forms that dissolve rapidly in the mouth without requiring water, making them particularly beneficial for patients who have difficulty swallowing. For instance, in July 2024, Adalvo Limited, a Malta-based pharmaceutical company, launched Desmopressin ODT in Europe to treat conditions that cause excessive fluid loss, such as central cranial diabetes insipidus. This synthetic vasopressin tablet helps manage diabetes insipidus, excessive thirst and urination, and bedwetting by mimicking the natural hormone and reducing water excretion in urine. Additionally, it is used to treat mild to moderate hemophilia A and von Willebrand disease by promoting the release of blood clotting factors.

In March 2022, Acerus Pharmaceuticals Corporation, a Canada-based biopharmaceutical company, acquired Serenity Pharmaceuticals LLC for an undisclosed amount. This acquisition granted Acerus Pharmaceuticals global rights to Noctiva, strengthening its portfolio in urology and men's health. The deal positions the company for accelerated growth and improved long-term performance. Serenity Pharmaceuticals LLC, a US-based pharmaceutical company, specializes in developing therapies for voiding disorders and urinary health conditions, including nocturia.

Major players in the nocturia market are Pfizer Inc, Merck & Co. Inc, AbbVie Inc, Sanofi S.A, GlaxoSmithKline plc, Viatris Inc, Boehringer Ingelheim International GmbH, Otsuka Pharmaceutical Co. Ltd, Astellas Pharma Inc, Eisai Co. Ltd., Sumitomo Dainippon Pharma Co. Ltd, Ferring Pharmaceuticals A/S, Avadel Pharmaceuticals plc, UroGen Pharma Ltd, Sanwa Kagaku Co. Ltd., Urovant Sciences Inc, Serenity Pharmaceuticals LLC, Vantia Therapeutics Inc, AA Pharma Inc, Wellesley Pharmaceuticals Inc.

North America was the largest region in the nocturia market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in nocturia report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the nocturia market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The nocturia market consists of revenues earned by entities by providing services such as diagnostic services, pharmacological treatment services, behavioral therapy and lifestyle modification services and telemedicine and remote consultation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The nocturia market also includes sales of bladder control devices, alpha-blockers, diuretics, and tricyclic antidepressants. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Nocturia Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on nocturia market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for nocturia ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The nocturia market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Drug: Anticholinergic Drugs; Desmopressin; Antibiotics; Antispasmodic; Other Drugs
2) By Indication: Mixed Nocturia; Low Nocturnal Bladder Capacity; Nocturnal Polyuria; Global Polyuria
3) By Causes: Urological Infection; Tumor Of The bladder; Diuretic Medications; Regular Alcohol Or coffee; Liver infection; Diabetes; Pregnancy; Other Causes
4) By End User: Hospitals; Home Care; Clinics
Subsegments:
1) By Anticholinergic Drugs: Oxybutynin; Tolterodine; Solifenacin; Darifenacin; Fesoterodine
2) By Desmopressin: Intranasal Desmopressin; Oral Desmopressin
3) By Antibiotics: Nitrofurantoin; Trimethoprim; Fosfomycin; Other Antibiotics
4) By Antispasmodic: Hyoscine Butylbromide; Flavoxate; Other Antispasmodics
5) By Other Drugs: Alpha-blockers; Beta-3 Agonists; Diuretics; Other Pharmacological Treatments
Companies Mentioned: Pfizer Inc; Merck & Co. Inc; AbbVie Inc; Sanofi S.A; GlaxoSmithKline plc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r34098

1. Executive Summary

2. Nocturia Market Characteristics

3. Nocturia Market Trends And Strategies

4. Nocturia Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Nocturia Growth Analysis And Strategic Analysis Framework

5.1. Global Nocturia PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Nocturia Market Growth Rate Analysis
5.4. Global Nocturia Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Nocturia Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Nocturia Total Addressable Market (TAM)

6. Nocturia Market Segmentation

6.1. Global Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Anticholinergic Drugs
Desmopressin
Antibiotics
Antispasmodic
Other Drugs
6.2. Global Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Mixed Nocturia
Low Nocturnal Bladder Capacity
Nocturnal Polyuria
Global Polyuria
6.3. Global Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Urological Infection
Tumor Of The bladder
Diuretic Medications
Regular Alcohol Or coffee
Liver infection
Diabetes
Pregnancy
Other Causes
6.4. Global Nocturia Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Home Care
Clinics
6.5. Global Nocturia Market, Sub-Segmentation Of Anticholinergic Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oxybutynin
Tolterodine
Solifenacin
Darifenacin
Fesoterodine
6.6. Global Nocturia Market, Sub-Segmentation Of Desmopressin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Intranasal Desmopressin
Oral Desmopressin
6.7. Global Nocturia Market, Sub-Segmentation Of Antibiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Nitrofurantoin
Trimethoprim
Fosfomycin
Other Antibiotics
6.8. Global Nocturia Market, Sub-Segmentation Of Antispasmodic, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hyoscine Butylbromide
Flavoxate
Other Antispasmodics
6.9. Global Nocturia Market, Sub-Segmentation Of Other Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Alpha-blockers
Beta-3 Agonists
Diuretics
Other Pharmacological Treatments

7. Nocturia Market Regional And Country Analysis

7.1. Global Nocturia Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Nocturia Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Nocturia Market

8.1. Asia-Pacific Nocturia Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Nocturia Market

9.1. China Nocturia Market Overview
9.2. China Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Nocturia Market

10.1. India Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Nocturia Market

11.1. Japan Nocturia Market Overview
11.2. Japan Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Nocturia Market

12.1. Australia Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Nocturia Market

13.1. Indonesia Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Nocturia Market

14.1. South Korea Nocturia Market Overview
14.2. South Korea Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Nocturia Market

15.1. Western Europe Nocturia Market Overview
15.2. Western Europe Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Nocturia Market

16.1. UK Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Nocturia Market

17.1. Germany Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Nocturia Market

18.1. France Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Nocturia Market

19.1. Italy Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Nocturia Market

20.1. Spain Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Nocturia Market

21.1. Eastern Europe Nocturia Market Overview
21.2. Eastern Europe Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Nocturia Market

22.1. Russia Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Nocturia Market

23.1. North America Nocturia Market Overview
23.2. North America Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Nocturia Market

24.1. USA Nocturia Market Overview
24.2. USA Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Nocturia Market

25.1. Canada Nocturia Market Overview
25.2. Canada Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Nocturia Market

26.1. South America Nocturia Market Overview
26.2. South America Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Nocturia Market

27.1. Brazil Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Nocturia Market

28.1. Middle East Nocturia Market Overview
28.2. Middle East Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Nocturia Market

29.1. Africa Nocturia Market Overview
29.2. Africa Nocturia Market, Segmentation By Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Nocturia Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Nocturia Market, Segmentation By Causes, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Nocturia Market Competitive Landscape And Company Profiles

30.1. Nocturia Market Competitive Landscape
30.2. Nocturia Market Company Profiles
- 30.2.1. Pfizer Inc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Merck & Co. Inc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. AbbVie Inc Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Sanofi S.A Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis

31. Nocturia Market Other Major And Innovative Companies

31.1. Viatris Inc
31.2. Boehringer Ingelheim International GmbH
31.3. Otsuka Pharmaceutical Co. Ltd
31.4. Astellas Pharma Inc
31.5. Eisai Co. Ltd.
31.6. Sumitomo Dainippon Pharma Co. Ltd
31.7. Ferring Pharmaceuticals A/S
31.8. Avadel Pharmaceuticals plc
31.9. UroGen Pharma Ltd
31.10. Sanwa Kagaku Co. Ltd.
31.11. Urovant Sciences Inc
31.12. Serenity Pharmaceuticals LLC
31.13. Vantia Therapeutics Inc
31.14. AA Pharma Inc
31.15. Wellesley Pharmaceuticals Inc

32. Global Nocturia Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Nocturia Market

34. Recent Developments In The Nocturia Market

35. Nocturia Market High Potential Countries, Segments and Strategies

35.1 Nocturia Market In 2029 - Countries Offering Most New Opportunities
35.2 Nocturia Market In 2029 - Segments Offering Most New Opportunities
35.3 Nocturia Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer